Navigation Links
IPC The Hospitalist Company Added to Russell 2000 Index
Date:4/3/2008

NORTH HOLLYWOOD, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading provider of hospitalist services, announced that it was added to the Russell 2000(R) Index effective March 31, 2008.

Adam Singer, M.D., Chief Executive Officer, commented, "This is another important milestone for IPC since becoming a publicly traded company. The addition to the Russell 2000(R) Index reflects our position as a leader in providing hospitalist services and will provide greater awareness and visibility for our stock among institutional investors."

The Russell 2000(R) Index measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000(R) Index is a subset of the Russell 3000(R) Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. Based on the monthly statistics as of February 29, 2008, the median market capitalization of the Russell 2000(R) Index was approximately $516 million.

The Russell 2000(R) Index is constructed to provide a comprehensive and unbiased small-cap barometer and is completely reconstituted annually to ensure larger stocks do not distort the performance and characteristics of the true small-cap opportunity set.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading physician group practice compan
'/>"/>

SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
11. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Chiropractic Marketing Online Coach Launches First of a Kind Wealth Club for Chiropractors 59719 1Chiropractic Marketing Online Coach Launches First of a Kind Wealth Club for Chiropractors 59719 2Athens Consulting Volunteers Time To Habitat For Humanity 59714 1Athens Consulting Volunteers Time To Habitat For Humanity 59714 2Migraine sufferers more prone to hangover headache 59709 1Migraine sufferers more prone to hangover headache 59709 2